CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study - Spyridopoulos, I. (Aging Cell, 2016)

High-throughput 13-parameter immunophenotyping identifies shifts in the circulating T-cell compartment following reperfusion in patients with acute myocardial infarction - Hoffmann, J. (PLoS ONE, 2012)

The Newcastle 85+ study: biological, clinical and psychosocial factors associated with healthy ageing: study protocol - Collerton, J. (BMC Geriatr., 2007)

Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study - Collerton, J. (BMJ, 2009)

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions - Sallusto, F.; Lenig, D.; Forster, R.; Lipp, M.; Lanzavecchia, A. (Nature, 1999)

Human CD8+ EMRA T cells display a senescence-associated secretory phenotype regulated by p38 MAPK - Callender, L. A. (Aging Cell, 2018)

Effect of ageing on CMV-specific CD8 T cells from CMV seropositive healthy donors - Pita-Lopez, M. L. (Immun. Ageing, 2009)

Hallmark features of immunosenescence are absent in familial longevity - Derhovanessian, E. (J. Immunol., 2010)

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC - McMurray, J. J. (Eur. Heart J., 2012)

Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study - Lam, C. S. P. (Eur. Heart J., 2018)

Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57 - Ibegbu, C. C. (J. Immunol., 2005)

Human CD8+ CD57− TEMRA cells: too young to be called “old” - Verma, K. (PLoS ONE, 2017)

Length-independent telomere damage drives post-mitotic cardiomyocyte senescence - Anderson, R. (EMBO J., 2019)

Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction - Walaszczyk, A. (Aging Cell, 2019)

Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice - Chang, J. (Nat. Med., 2016)

Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease - Hickson, L. J. (EBioMedicine, 2019)

Telomerase mediates lymphocyte proliferation but not the atherosclerosis-suppressive potential of regulatory T-Cells - Richardson, G. D. (Arterioscler Thromb. Vasc. Biol., 2018)

A natural product telomerase activator as part of a health maintenance program - Harley, C. B. (Rejuvenation Res., 2011)

Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study - Martin-Ruiz, C. (Mech. Ageing Dev., 2011)

Age-related frailty and its association with biological markers of ageing - Mitnitski, A. (BMC Med., 2015)